Skip to main content

Morphine-Induced Suppression of Thymocyte Proliferation is Mediated by Inhibition of IL-2 Synthesis

  • Chapter
The Brain Immune Axis and Substance Abuse

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 373))

Abstract

A correlation between chronic morphine use and immunosuppression has been well established in the recent past. The mechanisms responsible for these morphine induced changes in the immune system are unknown. There is evidence to show that this immunosuppression may be mediated either (1) directly through opiate receptors present on lymphocytes (Sibinga and Goldstein, 1988; Carr et al., 1988), (2) indirectly through opiate receptors in the central nervous system, or (3) by activation of the hypothalamic-pituitaryadrenal axis (George and Way, 1955) to release immunosuppressive glucocorticoid (Byat etal., 1991). Normal thymocytes and resting T-lymphocytes express low-affinity morphine receptors (Kd ~100 nM) (Madden et al., 1990; Roy et al., 1991). In addition, we have demonstrated that interleukin-1 (IL-1) activation of thymocytes results in a dramatic increase in specific binding of 3H-morphine on activated T-cells (Roy et al., 1991) This increase in binding results from both an increase in affinity (Kd 30 NM) as well as an increase in the number of receptors (Bmax). The physiological role of these binding sites is unknown. We hypothesize that induction of high affinity binding sites may directly mediate the effects of morphine on activated thymocytes and T-lymphocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Altman, A., Coggeshall K.M., and Mustelin T.,(1990) Molecular events mediating T cell activation. Adv.Immunol 48.227

    Article  PubMed  CAS  Google Scholar 

  • Bayer B.M., Daussin S., Hernandez M., Irvin, L., (1990) Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharm. 29: 369–374.

    Article  CAS  Google Scholar 

  • Bayer B.M., Hernandez M., Irvin, L., (1990) Supression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent. In: Pawloski A., Seminara D., atson R., eds. Alcohol Immunomodulation and AidsÊProceeding. New York A.R. Liss Inc. 273–282.

    Google Scholar 

  • Bryant H.U., Yoburn B.C., Intrissi C.E., Bernton E.W., and Holaday J.W (1988) Immunosupressive effects of chronic morphine treatment. Eur. J. Pharm 149; 165–169

    Article  CAS  Google Scholar 

  • Bryant, HU, Bernton, EW, Kenner, JR, Holaday, JW. (1991) Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinol. 128 (6):3253–3258.

    Article  CAS  Google Scholar 

  • Cantrell, D.A. and Smith K.A., (1984). The Il-2 T-cell system: a new cell growth model. Science 224:1313.

    Article  Google Scholar 

  • Carr, DJ, Klimpel, JR.(1986) Enhancement of the generation of cytotoxic T-cell by endogenous opiates. J.Neuroimmunoll. 12:75–87.

    Article  CAS  Google Scholar 

  • George, R, Way, EL. (1955) Studies on the mechanism of pituitary -adrenal activation by morphine. Br. J. Pharm. 10: 260–264.

    CAS  Google Scholar 

  • Madden, JJ, Donahue, RM.(1990) Opioid binding to cells of the immune system“ in Drugs of Abuse and the Immune system (ed. Watson, RR), pp.212–224. CRC Press, Boca Raton Fl.

    Google Scholar 

  • George R., Way E.L. (1955) Studies on the mechanism of pituitary -adrenal activation by morphine Br. J. Pharm. 10; 260–264

    CAS  Google Scholar 

  • Roy, S, Ge, BL, Ramakrishan, S, Lee, NM, Loh, HH.(1991) [3H]-morphine binding to thymocytes is enhanced by IL-1 stimulation. FEBS Letters 287:93–96.

    Article  PubMed  CAS  Google Scholar 

  • Roy, S, Ramakrishnan, S, Loh, HH, Lee, NM. (1991) Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur J Pharm 195: 359–363.

    Article  CAS  Google Scholar 

  • Smith, K.A., and Cantrell, D.A (1985) Interleukin 2 regulates its own receptor. Proc. Natl. Acad. Sci.USA 82:864–868

    Article  PubMed  CAS  Google Scholar 

  • Smith, K.A.(1989) Thelnterleukin 2 receptor. Ann.Rev.Cell.Biol. 5:397.

    Article  PubMed  CAS  Google Scholar 

  • Sei, Y, Yoshimoto, K, McIntyre, T, Skolnick, P, Arora, PK. (1991) Morphine induced thymic hypoplasia is glucocorticoid dependent. J. Immunol. 146(1): 194–198.

    PubMed  CAS  Google Scholar 

  • Sibinga, NES, Goldstein, A. (1988) Opioid peptides and opioid receptors in cells of the immune system Ó Ann. Rev. Immunol. 6:219–249.

    Article  CAS  Google Scholar 

  • Way, EL, Loh, HH, Shen, FH.(1968) Morphine tolerance, physical dependence, and synthesis of brain 5-HT. Science 162: 1290.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Roy, S., Loh, H.H., Barke, R.A. (1995). Morphine-Induced Suppression of Thymocyte Proliferation is Mediated by Inhibition of IL-2 Synthesis. In: Sharp, B.M., Eisenstein, T.K., Madden, J.J., Friedman, H. (eds) The Brain Immune Axis and Substance Abuse. Advances in Experimental Medicine and Biology, vol 373. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1951-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1951-5_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5801-5

  • Online ISBN: 978-1-4615-1951-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics